Clorox shares rose 4.3% after the company said first-quarter results were better than expected and maintained a path to modest underlying sales growth. The outlook still points to flat-to-slightly positive organic sales growth excluding the ERP benefit, with higher-than-expected input costs weighing on margins.
Shares rallied 9.6% following the quarterly report, driven by encouraging sequential market share gains and signs of stabilization in consumer demand despite ongoing category softness and macroeconomic uncertainty.
Clorox shares closed down 8.1% following Q3 FY26 results, as investors were disappointed by gross margin compression and slower-than-expected recovery in key segments, notably Litter and Food. Progress on market share gains and ERP stabilization were overshadowed by underwhelming improvement in several businesses and margin pressure from higher supply chain costs.
The Clorox Company demonstrated resilience in Q2 FY2026, reaffirming guidance amidst a challenging macroeconomic landscape and ongoing ERP implementation, while signaling optimism for the future driven by strategic initiatives.